{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:33:43Z","timestamp":1792427623626,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004503","name":"Benha University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004503","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Auris Nasus Larynx"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.anl.2025.06.009","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T04:13:29Z","timestamp":1750911209000},"page":"442-446","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Epstein-Barr virus (EBV) reactivation in post COVID-19"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9161-3149","authenticated-orcid":false,"given":"Eslam Farid Abu","family":"Shady","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelhakim Fouad","family":"Ghallab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doaa Abdullah","family":"Shaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha Abd Elhamid","family":"Elsayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.anl.2025.06.009_bib0001","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1099\/vir.0.18687-0","article-title":"Heterogeneous Epstein\u2013Barr virus latent gene expression in AIDS-associated lymphomas and in type I Burkitt's lymphoma cell lines","volume":"84","author":"Touitou","year":"2003","journal-title":"J Gen Virol"},{"issue":"3","key":"10.1016\/j.anl.2025.06.009_bib0002","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/jmv.24633","article-title":"Epstein\u2013Barr virus strains and variations: geographic or disease-specific variants?","volume":"89","author":"Neves","year":"2017","journal-title":"J Med Virol"},{"issue":"4","key":"10.1016\/j.anl.2025.06.009_bib0003","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/cas.13954","article-title":"Epstein-Barr virus strain variation and cancer","volume":"110","author":"Kanda","year":"2019","journal-title":"Cancer Sci"},{"issue":"5","key":"10.1016\/j.anl.2025.06.009_bib0004","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1073\/pnas.96.5.2279","article-title":"Crossreactive recognition of viral, self, and bacterial peptide ligands by human class I-restricted cytotoxic T lymphocyte clonotypes: implications for molecular mimicry in autoimmune disease","volume":"96","author":"Misko","year":"1999","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.anl.2025.06.009_bib0005","doi-asserted-by":"crossref","unstructured":"Takeuchi K., Tanaka-Taya K., Kazuyama Y., Ito Y.M., Hashimoto S., Fukayama M., et al. Prevalence of Epstein\u2013Barr virus in Japan: trends and future prediction. 2006;56(3):112\u20136.","DOI":"10.1111\/j.1440-1827.2006.01936.x"},{"key":"10.1016\/j.anl.2025.06.009_bib0006","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.587380","article-title":"Epstein-Barr virus and systemic autoimmune diseases","volume":"11","author":"Houen","year":"2021","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.anl.2025.06.009_bib0007","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000026453","article-title":"Stress-induced reactivation of Epstein-Barr virus in astronauts","volume":"8","author":"Stowe","year":"2000","journal-title":"Neuroimmunomodulation"},{"issue":"11","key":"10.1016\/j.anl.2025.06.009_bib0008","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1128\/JCM.39.11.3902-3905.2001","article-title":"Application of virus-specific immunoglobulin M (IgM), IgG, and IgA antibody detection with a polyantigenic enzyme-linked immunosorbent assay for diagnosis of Epstein-Barr virus infections in childhood","volume":"39","author":"Schaade","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.anl.2025.06.009_bib0009","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.m4938","article-title":"NICE guideline on long covid","author":"Sivan","year":"2020","journal-title":"Br Med J Publ Group"},{"issue":"2","key":"10.1016\/j.anl.2025.06.009_bib0010","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.0830","article-title":"Sequelae in adults at 6 months after COVID-19 infection","volume":"4","author":"Logue","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.anl.2025.06.009_bib0011","doi-asserted-by":"crossref","unstructured":"Chudzik M., Babicki M., Kapusta J., Ka\u0142uzi\u0144ska-Ko\u0142at \u017b., Ko\u0142at D., Jankowski P., et al. Long-COVID clinical features and risk factors: a retrospective analysis of patients from the STOP-COVID registry of the PoLoCOV study. 2022;14(8):1755.","DOI":"10.3390\/v14081755"},{"key":"10.1016\/j.anl.2025.06.009_bib0012","doi-asserted-by":"crossref","DOI":"10.1111\/all.15471","article-title":"Association between Epstein-Barr-Virus reactivation and development of long-COVID fatigue","author":"Rohrhofer","year":"2023","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.anl.2025.06.009_bib0013","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2022.04.037","article-title":"Postacute COVID-19 is characterized by gut viral antigen persistence in inflammatory bowel diseases","volume":"163","author":"Zollner","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.anl.2025.06.009_bib0014","doi-asserted-by":"crossref","unstructured":"Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., et al. Attributes and predictors of long COVID. 2021;27(4):626\u201331.","DOI":"10.1038\/s41591-021-01292-y"},{"issue":"4","key":"10.1016\/j.anl.2025.06.009_bib0015","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S1525-1578(10)60535-1","article-title":"Epstein-Barr virus quantitation by real-time PCR targeting multiple gene segments: a novel approach to screen for the virus in paraffin-embedded tissue and plasma","volume":"6","author":"Ryan","year":"2004","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.anl.2025.06.009_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2023.199157","article-title":"Incidence of Epstein-Barr virus reactivation is elevated in COVID-19 patients","volume":"334","author":"Bernal","year":"2023","journal-title":"Virus Res"},{"issue":"2","key":"10.1016\/j.anl.2025.06.009_bib0017","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10389-022-01802-3","article-title":"Post-COVID-19 syndrome: nature of symptoms and associated factors","volume":"32","author":"Mahmoud","year":"2024","journal-title":"J Public Health"},{"issue":"1","key":"10.1016\/j.anl.2025.06.009_bib0018","doi-asserted-by":"crossref","DOI":"10.2196\/36563","article-title":"Risk factors and characterization of post-COVID-19 syndrome in Jordan","volume":"8","author":"Almasri","year":"2022","journal-title":"Iproceedings"},{"key":"10.1016\/j.anl.2025.06.009_bib0019","article-title":"Long covid\u2014Mechanisms, risk factors, and management","volume":"374","author":"Crook","year":"2021","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.anl.2025.06.009_bib0020","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163669","article-title":"Chronic viral coinfections differentially affect the likelihood of developing long COVID","volume":"133","author":"Peluso","year":"2023","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.anl.2025.06.009_bib0021","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41591-021-01292-y","article-title":"Attributes and predictors of long COVID","volume":"27","author":"Sudre","year":"2021","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.anl.2025.06.009_bib0022","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.3390\/v14122629","article-title":"Long-COVID symptoms in individuals infected with different SARS-CoV-2 variants of concern: a systematic review of the literature","volume":"14","author":"Fern\u00e1ndez-de-Las-Pe\u00f1as","year":"2022","journal-title":"Viruses"},{"issue":"10","key":"10.1016\/j.anl.2025.06.009_bib0023","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1080\/23744235.2021.1924397","article-title":"Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments","volume":"53","author":"Yong","year":"2021","journal-title":"Infect Dis"},{"key":"10.1016\/j.anl.2025.06.009_bib0024","article-title":"Impact of pre-existing chronic viral infection and reactivation on the development of long COVID","author":"Peluso","year":"2022","journal-title":"medRxiv"},{"issue":"6","key":"10.1016\/j.anl.2025.06.009_bib0025","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1016\/j.jinf.2020.08.029","article-title":"Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19","volume":"81","author":"Garrigues","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.anl.2025.06.009_bib0026","article-title":"COVID-19, Epstein-Barr virus reactivation and autoimmunity: casual or causal liaisons?","author":"Tarasco","year":"2025","journal-title":"Immunol Infect"},{"issue":"1","key":"10.1016\/j.anl.2025.06.009_bib0027","article-title":"Positive Epstein\u2013Barr virus detection in coronavirus disease 2019 (COVID-19) patients","volume":"11","author":"Chen","year":"2021","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.anl.2025.06.009_bib0028","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.idnow.2021.07.005","article-title":"Herpesvirus reactivation during severe COVID-19 and high rate of immune defect","volume":"51","author":"Saade","year":"2021","journal-title":"Infect Dis Now"},{"key":"10.1016\/j.anl.2025.06.009_bib0029","article-title":"Impaired antibody-dependent cellular cytotoxicity in a Spanish cohort of patients with COVID-19 admitted to the ICU","volume":"12","author":"Vigon","year":"2021","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.anl.2025.06.009_bib0030","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.cmi.2020.09.052","article-title":"Follow-up of adults with noncritical COVID-19 two months after symptom onset","volume":"27","author":"Carvalho-Schneider","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.anl.2025.06.009_bib0031","article-title":"Association between Epstein-Barr-Virus reactivation and development of long-COVID fatigue","author":"Rohrhofer","year":"2022","journal-title":"Allergy"},{"issue":"9","key":"10.1016\/j.anl.2025.06.009_bib0032","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s00296-022-05146-9","article-title":"Herpesvirus infections and post-COVID-19 manifestations: a pilot observational study","volume":"42","author":"Zubchenko","year":"2022","journal-title":"Rheumatol Int"},{"issue":"4","key":"10.1016\/j.anl.2025.06.009_bib0033","doi-asserted-by":"crossref","first-page":"e597","DOI":"10.1002\/iid3.597","article-title":"COVID-19 associated EBV reactivation and effects of ganciclovir treatment","volume":"10","author":"Meng","year":"2022","journal-title":"Immun Inflamm Dis"}],"container-title":["Auris Nasus Larynx"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814625000975?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814625000975?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T02:04:21Z","timestamp":1762308261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0385814625000975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0385814625000975"],"URL":"https:\/\/doi.org\/10.1016\/j.anl.2025.06.009","relation":{},"ISSN":["0385-8146"],"issn-type":[{"value":"0385-8146","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epstein-Barr virus (EBV) reactivation in post COVID-19","name":"articletitle","label":"Article Title"},{"value":"Auris Nasus Larynx","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anl.2025.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Japanese Society of Otorhinolaryngology-Head and Neck Surgery, Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}